Balance Sheet for Menlo Therapeutics Inc. (MNLO)

$ 4.32   -0.02 (-0.46%) Volume: 18.28k 4:00 PM EDT 19-Jul-2019
After Hours:  $ 4.32 0.00 (0.00%) Volume: 493 5:04 PM EDT 19-Jul-2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 49,510 10,206 4,027 43,808
Restrictable Cash - - - -
Marketable Securities 86,740 49,295 26,881 -
Accounts Receivable - 786 - -
Loans Receivable - - - -
Other Receivables - - - -
Receivables - 786 - -
Inventories, Raw Materials - - - -
Inventories, Work in Progress - - - -
Inventories, Purchased Components - - - -
Inventories, Finished Goods - - - -
Inventories, Other - - - -
Inventories, Adjustments & Allowances - - - -
Inventories - - - -
Prepaid Expenses 3,250 3,574 632 77
Current Deferred Income Taxes - - - -
Other Current Assets - - - -
Total Current Assets 139,500 63,861 31,540 43,885
Land and Improvements - - - -
Buildings and Improvement - - - -
Machinery, Furniture and Equipment - - - -
Construction in Progress - - - -
Fixed Assets, Other 146 28 27 -
Fixed Assets, Total 146 28 27 -
Gross Fixed Assets 146 28 27 -
Accumulated Depreciation - - - -
Net Fixed Assets 146 28 27 -
Intangibles - - - -
Cost in Excess - - - -
Non-Current Deferred Income Taxes - - - -
Other Non-Current Assets - - - -
Total Non-Current Assets 428 3,006 10,513 -
Total Assets 139,928 66,867 42,053 43,885
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015
Accounts Payable 3,290 2,462 1,526 637
Short Term Debt - - - -
Notes Payable - - - -
Accrued Expenses 5,998 3,358 518 80
Accrued Liabilities 5,998 3,358 518 80
Deferred Revenues - 1,796 1,796 -
Current Deferred Income Taxes - - - -
Other Current Liabilities 256 201 63 53
Total Current Liabilities 9,544 7,817 3,903 770
Long Term Debt - - - -
Deferred Income Tax - 6,735 8,531 -
Other Non-Current Liabilities 7 6,757 8,588 65
Minority Interest - - - -
Capital Lease Obligations - - - -
Preferred Securities of Subsidiary Trust - - - -
Preferred Equity Outside Shareholders' Equity - 109,327 59,003 59,003
Total Non-Current Liabilities 7 116,084 67,591 59,068
Total Liabilities 9,551 123,901 71,494 59,838
Preferred Shareholder's Equity - - - -
Common Shareholder's Equity 130,377 (57,034) (29,441) (15,953)
Common Par 3 1 1 1
Additional Paid in Capital 241,106 2,207 699 93
Cumulative Translation Adjustments - - - -
Retained Earnings (110,636) (59,191) (30,115) (16,047)
Treasury Stock - - - -
Other Equity Adjustments (96) (51) (26) -
Total Capitalization 130,377 (57,034) (29,441) (15,953)
Total Equity 130,377 (57,034) (29,441) (15,953)
Total Liabilities & Shareholder's Equity 139,928 66,867 42,053 43,885
Cash Flow (50,692) (29,149) (14,230) (4,608)
Working Capital 129,956 56,044 27,637 43,115
Free Cash Flow (52,873) (28,249) (2,322) (4,183)
Invested Capital 130,377 (57,034) (29,441) (15,953)
Shares Outstanding - Common Class Only 23,233 - - -
Preferred Shares Outstanding - - - -
Total Ordinary Shares 23,233 20,595 20,595 20,595
Total Common Shares Outstanding 23,233 - - -
Treasury Shares - - - -
Basic Weighted Shares Outstanding 21,669 20,595 10,222 11,539
Diluted Weighted Shares Outstanding 21,669 20,595 10,222 11,539